Theranexus
Clinical-stage biopharmaceutical company developing treatments for rare neurological disorders.
ALTHX | PA
Overview
Corporate Details
- ISIN(s):
- FR0013286259
- LEI:
- 969500BFCV6IC7MFQP20
- Country:
- France
- Address:
- 60 AVENUE ROCKEFELLER, 69008 LYON
- Website:
- https://www.theranexus.com/en/
- Sector:
- Manufacturing
Description
THX Pharma (formerly Theranexus) is an innovative, clinical-stage biopharmaceutical company that emerged from the French Alternative Energies and Atomic Energy Commission (CEA). The company specializes in developing treatments for rare neurological disorders. It leverages a unique platform for the identification and characterization of advanced therapy drug candidates. Its lead program is a drug candidate in clinical development for Batten disease, a rare neurodegenerative disorder.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2018-04-23 07:30 |
LE THN102 OBTIENT LE STATUT D'INVESTIGATIONAL NEW DRUG DE LA FOOD AND DRUG ADMI…
|
French | 808.8 KB | ||
| 2018-04-19 18:00 |
THERANEXUS ANNOUNCES THE FIRST EUROPEAN APPROVAL FOR ITS PHASE 2 CLINICAL TRIAL…
|
English | 1.0 MB | ||
| 2018-04-19 18:00 |
THERANEXUS ANNONCE L'OBTENTION D'UNE PREMIERE AUTORISATION EUROPEENNE POUR L'ET…
|
French | 277.9 KB | ||
| 2018-03-21 07:30 |
THERANEXUS ANNOUNCES A SUCCESSFUL CLINICAL PHARMACOKINETIC STUDY AS PART OF THE…
|
English | 309.4 KB | ||
| 2018-03-21 07:30 |
THERANEXUS ANNONCE LE FRANCHISSEMENT D'UNE ETAPE DE PHARMACOCINETIQUE CLINIQUE …
|
French | 314.9 KB | ||
| 2018-03-15 07:30 |
THERANEXUS AND THE COLLEGE DE FRANCE SIGN A RESEARCH AGREEMENT ON ASTROCYTE-NEU…
|
English | 184.3 KB | ||
| 2018-03-15 07:30 |
THERANEXUS ET LE COLLEGE DE FRANCE SIGNENT UNE COLLABORATION DE RECHERCHE SUR L…
|
French | 187.7 KB | ||
| 2018-01-29 18:15 |
THERANEXUS PUBLIE SON AGENDA FINANCIER 2018
|
French | 695.9 KB | ||
| 2018-01-17 18:00 |
BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE - 2ND SEMESTRE 2017
|
French | 554.2 KB |
Automate Your Workflow. Get a real-time feed of all Theranexus filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Theranexus
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Theranexus via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
